Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids With Further CSA Elimination In The Rapamune Arm With The Introduction Of MMF

NCT01601821 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01601821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01601821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids With Further CSA Elimination In The Rapamune Arm With The Introduction Of MMF
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2008
Enrollment
245 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation